Aspen Pharmacare annual normalised earnings rise 22% on Mounjaro demand
Aspen Pharmacare (APN) reported annual normalised earnings up 22%, citing strong demand for obesity and diabetes treatment Mounjaro it distributes and improving profitability in its manufacturing business.